VASCULAR THERAPIES

Vascular Therapies is a biotechnology company focused on improving patient outcomes by reducing surgical stenosis in patients with kidney and vascular disease. The company has developed Sirogen™, an investigational sirolimus formulation for local, perivascular drug delivery... A functional, lasting vascular access is the lifeline for hemodialysis patients. Vascular Therapies is improving vascular access by reducing surgical stenosis... Vascular Therapies' Board of Directors is comprised of experts from the fields of medicine, medical technology, finance, and life science investing.

Primary location: Cresskill United States